Last reviewed · How we verify

NCT06148116

Attitudes and Knowledge of Dialysis Patients Towards Kidney Transplantation

Status unknown Last updated 28 November 2023
What this trial tests

trial in Kidney Transplant in 2,000 participants. Status unknown.

Timeline
1 July 2023
Primary endpoint
31 August 2024
30 September 2024

Quick facts

Lead sponsorAndrzej Frycz Modrzewski Krakow University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,000
Start date1 July 2023
Primary completion31 August 2024
Estimated completion30 September 2024
Sites1 location across Poland

Conditions studied

Sponsor

Andrzej Frycz Modrzewski Krakow University

Who can join

18 and older, any sex, with Kidney Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In Poland, approximately 4.2 million people suffer from chronic kidney disease \[1\]. In December 2022, a total of 20,198 patients were dialyzed in the country, of which 96% by hemodialysis (HD) and 4% by peritoneal dialysis (DO). In 2022, kidney transplantation was performed in 2.6% of patients dialyzed using the HD method and in 15.4% of patients dialyzed using the DO method \[2\]. According to the data of the Organizational and Coordination Center for Transplantation "Poltransplant", in 2022 on the national waiting list 1,119 people were registered for kidney transplantation. The average age of those waiting was 49 years \[3\]. In Poland, according to data from 2022, the average waiting time for transplantation in the case of the first transplant from the moment of registration on the waiting list was 387 days, and 1,106 days from the start of dialysis. Data show that only 5.5% of patients undergoing renal replacement therapy are on the waiting list \[3\]. Therefore, a study was designed to examine the knowledge and attitudes towards kidney transplantation among dialysis patients. The study will include a representative group of dialysis patients from all voivodeships and aims to identify positive and negative aspects related to patients' attitudes towards kidney transplantation. The scientific value of the study is worth emphasizing, because so far in Poland no research has been conducted on the knowledge and attitudes towards kidney transplantation among dialysis patients in all voivodeships in the country. The study will identify the level of knowledge and attitudes of dialysis patients towards transplantation. The results of this study may contribute to the development and implementation of new educational and information programs that may increase the level of knowledge and influence attitudes towards transplantation, which may largely contribute to the increase in transplantation among people with chronic kidney disease. References: 1. Gellert R, Durlik M, Małgorzewicz S. Raport 2019. Ogólnopolskie Badanie Pacjentów Nefrologicznych. Forum Nefrologiczne. 2020;13(3):149-63. 2. Dębska-Ślizień A, Rutkowski B, Rutkowski P et al. (2022). Aktualny stan leczenia nerkozastępczego w Polsce-2022. Nefrol Dializoter Pol, 26: 21-38. 3. Centrum Organizacyjno- Koordynacyjne do spraw transplantacji-Poltransplant. Biuletyn Informacyjny 2023. https://files.poltransplant.org.pl/Biuletyn\_2023\_www.pdf Accessed 13 November 2023.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Factors associated with the willingness to become a kidney transplant recipient ─ the results from a national cross sectional study.
    Kurleto P, Tomaszek L, Milaniak I, Dębska G, et al · · 2025 · PMID 41102657 · DOI 10.1186/s12882-025-04516-2

Verify or expand the search:

Other recruiting trials for Kidney Transplant

Currently open trials in the same condition.

Other Andrzej Frycz Modrzewski Krakow University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06148116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing